|
|
|
Vol. 13, No. 19, pp. 2538-2548, October 1, 1999
1 Max-Delbrück-Center for Molecular Medicine, 13092 Berlin, Germany; 2 Friedrich Miescher Institut, 4058 Basel, Switzerland; 3 The Victor Chang Cardiac Research Institute, Darlinghurst 2010, Australia
| |
Abstract |
|---|
|
|
|---|
The ErbB2 tyrosine kinase functions as coreceptor for the neuregulin
receptors ErbB3 and ErbB4 and can participate in signaling of EGF
receptor (ErbB1), interleukin receptor gp130, and G-protein coupled
receptors. ErbB2
/
mice die at
midgestation because of heart malformation. Here, we report a genetic
rescue of their heart development by myocardial expression of erbB2
cDNA that allows survival of the mutants to birth. In rescued
erbB2 mutants, Schwann cells are lacking. Motoneurons form and
can project to muscle, but nerves are poorly fasciculated and
disorganized. Neuromuscular junctions form, as reflected in clustering
of AChR and postsynaptic expression of the genes encoding the
-AChR,
AChE,
-AChR, and the RI subunit of the cAMP protein kinase. However,
a severe loss of motoneurons on cervical and lumbar, but not on
thoracic levels occurs. Our results define the roles of Schwann cells
during motoneuron and synapse development, and reveal different
survival requirements for distinct motoneuron populations.
[Key Words: Motoneuron loss; neuromuscular synapse; coreceptor; neuregulin; AChR]
| |
Introduction |
|---|
|
|
|---|
The erbB2 (c-neu, HER2) gene encodes one
of the four members of the mammalian ErbB family of receptor tyrosine
kinases (Weiss et al. 1997
; Tzahar and Yarden 1998
).
ErbB2 has oncogenic potential when mutated or overexpressed,
and is frequently amplified and/or overexpressed in human
carcinomas. Despite an intensive search, no high-affinity ligand has
been identified for ErbB2. Biochemical analyses indicate that ErbB2
acts as a coreceptor for ErbB3 and ErbB4 (Goldman et al. 1990
; Carraway
and Cantley 1994
) and ErbB1 (the EGF receptor). ErbB2 has been
implicated in signaling of interleukins, and forms complexes with the
gp130 subunit of the IL-6 receptor (Qiu et al. 1998
). Moreover, ErbB2
is transactivated on signaling of G-protein-coupled receptors (Daub et
al. 1996
). Genetic evidence shows that ErbB2 participates in the
transmission of signals given by neuregulin-1 (Burden and Yarden 1997
).
From the single neuregulin-1 gene, many different isoforms of the
factor are produced by the usage of different promoters and by
alternative splicing. These isoforms bind ErbB4 and/or
ErbB3, and were characterized independently as (1) a factor able to
induce tyrosine phosphorylation of the ErbB2 receptor as well as growth
and differentiation of epithelial cells (NDF or heregulin; Holmes et
al. 1992
; Wen et al. 1992
); (2) a mitogen for Schwann cells (glial
growth factor; Marchionni et al. 1993
); and (3) an inducer of
acetylcholine receptor (AChR) expression in cultured myoblasts (AChR
inducing activity, ARIA; Falls et al. 1993
).
The ErbB3 receptor resembles other receptors of the ErbB family in
general structure (Kraus et al. 1989
; Plowman et al. 1990
). However,
the sequence of the ErbB3 tyrosine kinase domain diverges from the
consensus tyrosine kinase sequence, and ErbB3 has no or only very low
tyrosine kinase activity, even in the presence of its high-affinity
ligand neuregulin-1. However, when coexpressed with the EGF receptor,
ErbB2 or ErbB4, tyrosine phosphorylation of ErbB3 is observed in
response to ligands like EGF or neuregulin-1 (Lenferink et al. 1998
;
Pinkas et al. 1998
; Riese and Stern 1998
). Biochemical evidence thus
shows that various receptors of the ErbB family can function as
coreceptors for ErbB3, which appear to provide in trans the
tyrosine kinase activity necessary for ErbB3 signaling. Tyrosine
phosphorylation of ErbB3 results in the generation of docking sites for
substrates like PI-3-kinase (Tzahar and Yarden 1998
).
Mice with erbB2 null mutations die before E11 (Lee et al.
1995
). Analysis of these animals showed that ErbB2 is required for heart morphogenesis and the development of neural crest cells and their
derivatives (Lee et al. 1995
; Erickson et al. 1997
; Britsch et al.
1998
). In such mice, a marked reduction of Schwann cell precursors that
accompany the spinal nerves is observed at E10.5, and cranial sensory
and sympathetic ganglia are severely hypoplastic. The phenotypes in
neural crest cell derivatives are similar in erbB3,
erbB2, and neuregulin-1 mutant mice at this stage,
indicating that ErbB2/ErbB3 heterodimers transmit the
neuregulin-1 signal in neural crest cells (Lee et al. 1995
; Meyer and
Birchmeier 1995
; Erickson et al. 1997
; Riethmacher et al. 1997
; Britsch
et al. 1998
). In contrast, erbB4, erbB2, and
neuregulin-1 mutant mice display similar phenotypes in the
heart ventricles, indicating that ErbB2/ErbB4
heterodimers transmit the neuregulin-1 signal in the myocardium
(Gassmann et al. 1995
; Lee et al. 1995
; Meyer and Birchmeier 1995
;
Erickson et al. 1997
).
The functional analysis of ErbB2 was limited, as mice with
erbB2 null mutations die at midgestation (Lee et al. 1995
;
Erickson et al. 1997
; Britsch et al. 1998
). We rescued the mutant
embryos by the expression of erbB2 cDNA under the control of the
heart-specific Nkx2.5 promoter. This enabled us to analyze
erbB2 function during late developmental stages.
We demonstrate that in rescued erbB2 mutant mice,
neuromuscular junctions form, as reflected in clustering of AChR and
postsynaptic expression of the genes encoding the
-AChR, AChE,
-AChR, and the RI subunit of the cAMP protein kinase. Thus,
synapse formation and maturation take place, despite the absence of
Schwann cells observed in these animals and despite the lack of ErbB2
receptor in the muscle. However, a severe loss of motoneurons on
cervical and lumbar, but not on thoracic levels, occurs. Our results
define the roles of Schwann cells during motoneuron and synapse
development, and reveal different survival requirements for distinct
motoneuron populations.
| |
Results |
|---|
|
|
|---|
Generation of the Nkx2.5erbB2 allele
The lethality of erbB2
/
mice at E11 was attributed to myocardial malformation (Lee et al. 1995
;
Erickson et al. 1997
; Britsch et al. 1998
). To rescue the
erbB2 mutants, we expressed erbB2 cDNA under the control of
the Nkx2.5 gene, which is expressed specifically in the
myocardium (Lints et al. 1993
). Rat erbB2 cDNA was inserted
into exon 1 of Nkx2.5 by homologous recombination in ES cells
(Fig. 1A,B), and mutant ES cells were used to
generate mice that express the erbB2 cDNA under the control of the
Nkx2.5 promoter. Animals with one copy of the
Nkx2.5erbB2 allele did not display an overt
phenotype and were fertile. However, erbB2
/
embryos that carry in
addition one Nkx2.5erbB2 allele survived beyond E11
(Table 1). At E10.5, the expected Mendelian ratio of
rescued erbB2
/
was observed.
Some rescued erbB2
/
embryos
were lost between E12.5 and E14.5. At E14.5 and E18.5, their frequency
corresponded to 5%-6% (Table 1). A similar reduced survival was
observed previously for erbB3
/
embryos (Riethmacher et al. 1997
). At birth, rescued erbB2
mutant animals displayed an overall size reduction, they were cyanotic, did not breathe or move spontaneously, and their lung alveoli did not
expand, although the heart continued to beat for some time.
|
|
We found that the Nkx2.5erbB2 allele rescues
trabeculation of the heart ventricle of erbB2 mutants at E10.5
(Fig. 1D). Compared with control animals, the extent of trabeculation
is moderately reduced (Fig. 1D, cf. a and b). At E18.5, the heart of
rescued erbB2 mutant embryos is well developed, although it is
smaller by ~30%, which corresponds to the reduced size of the
entire animal. RT-PCR analysis demonstrated that transcripts derived
from the Nkx2.5erbB2 allele are present in the
heart, but not in skeletal muscle or in brain of rescued erbB2
mutant embryos (Fig. 1C). Thus, expression of erbB2 cDNA under the
control of the Nkx2.5 promoter rescues heart development in
erbB2
/
mice and can allow
survival of the mutants to birth.
Essential functions of erbB2 in development of Schwann cells and other neural crest cell derivatives
Rescued erbB2 mutant embryos, like erbB3 mutant embryos, displayed defects in the development of Schwann cells and other neural crest cell derivatives. At early stages (E10.5, E12.5), severe reductions in the numbers of Schwann cell precursors were observed in the roots of spinal nerves. Sox10 or P0-positive Schwann cell precursors are lacking in distal portions of peripheral nerves, that is, along cutaneous and intercostal nerves at E12.5 or E15.5 (Fig. 2, cf. b and c and e and f with controls in a and d, respectively). Semithin sections through the nerves of the brachial plexus of rescued erbB2 and in erbB3 mutant embryos at E15.5 demonstrate a reduced nerve diameter (Fig. 2, compare h and i with control in g); nuclei within the nerve are rare (arrowhead in Fig. 2i). A histologically defined layer of cells that surround nerves was observed (arrows in Fig. 2h,i; cf. control in g), whose identity is unclear as these cells neither express Sox10, Po, nor Patched (not shown). Immunohistology indicated that S100-positive cells were not detected at synapses or in distal projections in thoracic muscle at E15.5 or E18.5 (Fig. 5, below, cf. k and l with control in j). However, at E18.5, we observed cells associated with large nerve bundles that display a weak S100-staining (not shown).
|
Dorsal root ganglia formed in rescued erbB2 mutants and
contained a normal number of cells at E12.5 (Fig.
3c). Staining of E12.5 embryos with anti-L1
antibodies indicates that the overall trajectories of cutaneous sensory
nerves are not severely altered and that these nerves project to the
skin in rescued erbB2 mutants (Fig. 3b). However, sensory
cutaneous nerves are severely defasciculated when compared with control
embryos (Fig. 3, cf. b with control in a). The appearance of sensory
cutaneous nerves is similar in erbB3 mutants (not shown). At
E14.5 and at later stages, a severe loss of sensory neurons in dorsal
root ganglia was observed on all axial levels (Fig. 3c). This is
similar to the loss of sensory neurons observed in erbB3
mutants (Fig. 3, cf. c with Riethmacher et al. 1997
). In contrast,
cranial and sympathetic ganglia were hypoplastic at E10.5, that is, at
the time these structures form (cf. Lee et al. 1995
; Erickson et al.
1997
; Britsch et al. 1998
).
|
Loss of distinct motoneuron populations in rescued erbB2 mutant mice
Motoneuron numbers were determined on different axial levels by in
situ hybridization with probes specific for VAChT
(vesicular acetylcholine
transporter); VAChT is strongly expressed in motoneurons (Naciff et al. 1997
; cf. Fig. 4a,b). At E15.5,
numbers of motoneurons were comparable in control and mutant embryos on
thoracic and lumbar levels. Rescued erbB2 and erbB3
mutants displayed already moderate reductions in motoneuron numbers in
cervical segments when compared with control embryos at this stage
(Fig. 4c). In contrast, at E18.5, large proportions of motoneurons were
lost on cervical and lumbar levels, whereas motoneurons in thoracic segments were minimally affected (Fig. 4d). Thus, motoneurons form, but
subsequently degenerate on cervical and lumbar axial levels.
|
Nerve morphology and neuromuscular synapse formation in rescued erbB2 mutant embryos
Immunohistology with anti-L1 or anti-GAP43 antibodies revealed an abnormal morphology of nerve projections and nerve terminals in mutant embryos. We concentrated our analysis on motor nerves originating from thoracic segments of the spinal cord, which are only minimally affected by motoneuron loss in the mutants. In wild-type E15.5 embryos, single bundles of intercostal nerves are observed from which side branches project to synaptic areas at regular intervals (Fig.5a). In rescued erbB2 mutants, and in erbB3 mutants at this stage, intercostal nerves are split into several bundles that run in parallel, and side branches are poorly fasciculated and disorganized (Fig. 5b,c). The morphology of intercostal nerves in mutant embryos is similar at E18.5. The phrenic nerve in the diaphragm of rescued erbB2 and of erbB3 mutants at E14.5 is thin and defasciculated. At E15.5, the phrenic nerve in the diaphragm is frequently fragmented and, at later stages, only remnants of the nerve are detectable. This coincides with the loss of motoneurons on cervical levels from which the phrenic nerve originates. In addition, the diaphragm muscle is notably thinned at E18.5 (not shown).
|
Restoration of erbB2 expression in the heart allowed us to
study the potential role of ErbB2 in neuromuscular synaptogenesis. Neuromuscular synapses were visualized by staining with
rhodamine-labeled
-bungarotoxin, which revealed that AChR clusters
are formed and persist in thoracic muscle of rescued erbB2
mutants and of erbB3 mutants. At E18.5, a general
disorganization of the nerves was observed that appear defasciculated
(Fig. 5d-i). Frequently, AChR clusters were detected at multiple sites
along single nerve bundles in mutants (arrowheads in Fig. 5h,i), and
the clusters were often enlarged and nonhomogeneously stained (arrows).
In addition, ectopic AChR clusters that were not contacted by nerves
were detected in both mutants (not shown). At E15.5, the distribution
of AChR clusters was similar in intercostal muscle of rescued
erbB2 mutants and of erbB3 mutants. Ultrastructural
analysis of synapses in intercostal muscle of rescued erbB2
mutants at E15.5 revealed close nerve-muscle contacts; however,
terminal Schwann cells were absent (Fig. 6). Synaptic
vesicle accumulations (arrowheads in Fig. 6) and putative pre- and
postsynaptic densities were observed. In the wild type, nerve-muscle
contact sites were restricted to synaptic profiles, whereas contact
regions extending over several tens of microns were detected in the
mutant (Fig. 6). The general morphology of nerve and synapses is
similar in erbB3 mutants but, compared with rescued
erbB2 mutants, the disorganization appears more pronounced
(not shown). Clustered AChR are also observed in the diaphragm at E15.5
in rescued erbB2 mutants and in erbB3 mutants, and
were present not only in the center of diaphragm muscle, but also at
its borders. Frequently, the nerve had apparently withdrawn from the
AChR clusters (not shown).
|
We analyzed post-synaptically expressed genes in intercostal and
diaphragm muscles at E18.5, that is, muscle innervated by motor nerves
that derive from thoracic (intercostal) and from cervical (diaphragm)
axial levels. In innervated muscle, expression of
-AChR,
RI-PKA, and AChE is restricted to post-synaptic
nuclei, and induction of
-AChR is observed when synapses
mature (Witzemann et al. 1991
; Imaizumi et al. 1996
; Massoulie et al.
1998
). In intercostal muscles, postsynaptic expression of
-AChR, RI-PKA, AChE, and of low levels
of
-AChR were observed in rescued erbB2 mutants,
in erbB3 mutants, and in control animals (Fig. 7a-f; data not
shown). Signal intensities appeared moderately
reduced with
-AChR, RI-PKA, and AChE
probes, and bands of expressing nuclei were broader. Occasionally,
muscle fibers that did not show restricted
-AChR
expression were noted (arrowheads in Fig. 7e,f). Despite the early
withdrawal of the phrenic nerve, post-synaptic expression of
-AChR, RI-PKA, AChE, and
-AChR was also observed in the diaphragm muscle of
rescued erbB2 and of erbB3 mutants (Fig. 7g-l; data
not shown). Intensities of the in situ hybridization signals associated
with synaptic nuclei were significantly reduced in the diaphragm.
Moreover, nuclei expressing these genes were distributed in an abnormal
pattern (arrowhead in Fig. 7h). However, extrasynaptic down-regulation
of
-AChR was incomplete in the diaphragm of mutant
embryos, reflecting the early withdrawal of the phrenic nerve (not
shown). In limb muscles of rescued erbB2 and erbB3
mutants, postsynaptic expression of
-AChR was also apparent, but down-regulation of
-AChR expression was
incomplete in extra-synaptic nuclei (not shown).
|
| |
Discussion |
|---|
|
|
|---|
Here, we report a genetic rescue of erbB2-deficient mice by
expression of erbB2 cDNA in the myocardium, which demonstrates that the
midgestation lethality of null mutants is caused by myocardial malformation. The severe abnormality in development of Schwann cells
and neural crest cell derivatives is similar in rescued erbB2
and in erbB3 mutants. We suggest that these cells use the ErbB2/ErbB3 heterodimer as the neuregulin receptor. It is
interesting to note that neither the ErbB4 nor the EGF receptors, which
can provide a coreceptor function for ErbB3 in vitro, are able to take
over such a role in neural crest cells in vivo. Biochemical evidence
indicates an additional role of ErbB2 in signaling of the EGF-receptor,
the interleukin receptor gp130, and of G-protein-coupled receptors
(Goldman et al. 1990
; Daub et al. 1996
; Qiu et al. 1998
). Despite many
potential functions of ErbB2, rescued erbB2 mutants are
remarkably similar to erbB3 mutants, indicating that the major physiological role of ErbB2 during development is to provide a coreceptor function for neuregulin receptors ErbB3 and ErbB4.
Loss of motoneuron subpopulations and of sensory neurons in rescued erbB2 mutants
A severe loss of motoneurons is observed in rescued erbB2
and erbB3 mutants in the cervical and lumbar spinal cord at
E18.5, whereas thoracic motoneurons are minimally affected. Thus,
cervical and lumbar motoneurons appear to differ from thoracic
motoneurons in their requirement for, or their sensitivity toward,
trophic factors that are absent in the mutants. It is well established that spinal motoneurons are heterogeneous and differ in expression of
genes encoding transcription factors such as members of the Lim family
(Tsuchida et al. 1994
). Lim factors determine motoneuron identity, and
subdivide motoneurons into different classes that take characteristic
paths to their targets. Differentially expressed transcription factors
could thus provide the molecular basis for distinct sensitivities
toward trophic factors. For instance, motoneuron subpopulations express
different levels of the c-met receptor tyrosine kinase, whose
activity can affect motoneuron survival. SF/HGF, the
ligand of c-Met, as well as a muscle-derived factor of unknown
molecular structure (CDF, ChAT development factor) differentially
promote survival of cultured motoneurons that derive from distinct
axial levels (McManaman et al. 1990
; Yamamoto et al. 1997
). Selective
loss of motoneuron subpopulations was not reported previously in mutant
mice during development. However, degenerative motoneuron diseases in
mice and man can primarily affect motoneurons on particular axial
levels. This raises the intriguing possibility that related molecular
mechanisms function in differential survival of motoneurons during
development and in motoneuron diseases in the adult.
The proportion of motoneuron loss at different axial levels is similar
in rescued erbB2 mutants and in erbB3 mutants.
ErbB3 is not required in a cell autonomous manner for survival
of sensory or motoneurons (Riethmacher et al. 1997
). We suggest that
erbB2 acts in a similar manner and affects motoneuron survival
indirectly. Differentiating Schwann-cells or Schwann cell precursors
might provide the trophic support missing in the mutants; trophic
support could be provided by soluble factors or by direct contact
between Schwann cells and axons. Schwann cells in vitro produce various neurotrophic factors that might affect motoneuron survival in vivo
(Bunge 1993
). Alternatively, ErbB2 and ErbB3 expressed in skeletal
muscle could regulate the expression of motoneuron survival factors.
Cell type-specific ablation of erbB2 in Schwann-cell precursors or skeletal muscle will allow the determination of the
source of the neurotrophic factor(s) in the future. In rescued erbB2 or in erbB3 mutants, abnormal loss of
motoneurons occurs after E15.5 in the lumbar spinal cord. Naturally
occurring motoneuron loss or abnormal motoneuron loss induced by
experimental ablation of skeletal muscle occurs between E13.5 and birth
on lumbar axial levels, and thus in an overlapping, but not identical
time frame (Grieshammer et al. 1998
).
Development of Schwann cells and sensory nerves in rescued erbB2 mutant mice
Schwann cells accompany sensory and motoneurons and derive from the
neural crest (Le Douarin 1982
). In erbB2 null mutant mice, the
number of Schwann-cell precursors is already severely reduced at E10.5
(S. Britsch and C. Birchmeier, unpubl.). At early stages, reduced
numbers of Sox10-positive or P0-positive cells are detected in portions of sensory and motor nerves close to the spinal cord, but
are absent in the periphery, for instance, along phrenic or intercostal
nerves of rescued erbB2 mutants. Thus, the few precursor cells
present do not expand, nor do they migrate along the axons. However, a
cellular layer that surrounds nerve bundles is apparent. These cells
express neither marker (Sox10 or P0) typical for Schwann cells, Schwann-cell precursors or neural crest cells, nor do they express a marker for the perineurium (patched; S. Britsch and C. Birchmeier, unpubl.). Patched encodes a hedgehog receptor
and is expressed in the embryonal perineurium, whose development is in
part controlled by desert hedgehog produced by Schwann cells (Parmantier et al. 1999
). The observed cellular layer might therefore correspond to an abnormal perineurium. Alternatively, it might originate from neural crest cells that ceased to express genes typical
for the lineage. The absence of Schwann cells in rescued erbB2
mutant embryos may contribute to the abnormal morphology of nerves, and
our results are compatible with a functional role of Schwann cells in
organization and bundling of peripheral nerves.
Despite the disorganization and severe defasciculation of sensory nerves, the general trajectory appears similar in control and rescued erbB2 mutants. However, we observe a severe loss of sensory neurons that starts after E12.5 on lumbar axial levels. In contrast to the loss of motoneurons, sensory neuron loss is not restricted to particular axial levels, but is pronounced in all dorsal root ganglia at E18. At earlier stages, cranio-caudal gradients in the extent of degeneration are apparent. Time course and extent of degeneration of sensory neurons are similar in rescued erbB2 and erbB3 mutants. We have demonstrated previously that erbB3 is not required in a cell-autonomous manner for survival of sensory neurons. We suggest that erbB2 acts in a similar manner and affects the survival of sensory neurons indirectly.
Neuromuscular synapse formation and postsynaptic gene expression in rescued erbB2 mutants
Genetic analysis in mice has provided new insights into the
molecular control of neuromuscular synaptogenesis (Sanes and Lichtman 1999
). Neuronal agrin initiates synaptogenesis, and ablation of the
agrin gene results in incomplete AChR clustering and lack of
postsynaptic specialization (McMahan 1990
; Gautam et al. 1996
). MuSK, a
muscle-specific tyrosine kinase receptor, might function in the
recognition of agrin, because
MuSK
/
mice do not form
synapses. However, MuSK does not bind agrin directly (DeChiara et al.
1996
; Glass et al. 1996
). Rapsyn, a downstream cytoplasmic component,
is essential for clustering of AChR and ErbB2 as well as for
postsynaptic specialization (Gautam et al. 1995
; Moscoso et al. 1995
).
Despite a lack of, or a severe impairment in formation of synapses,
loss of motoneurons was not reported in such mutant mice. Thus, synapse
formation appears not to be essential for motoneuron survival if axons
reach their targets. Synapse formation is not sufficient for motoneuron
survival in rescued erbB2 and in erbB3 mutants, as
pronounced motoneuron loss is detected although synapses form.
Neuregulin induces AChR expression in cultured muscle cells,
and it was postulated to induce postsynaptic expression of the AChR subunit genes (Missias et al. 1996
; Fischbach and Rosen
1997
; Fromm and Burden 1998
; Rimer et al. 1998
; Schaeffer et al. 1998
). In accordance with an important role in neuromuscular junctions, neuregulin-1 and the ErbB2, ErbB3, and ErbB4 receptors are clustered at
the synapses (Altiok et al. 1995
; Jo et al. 1995
; Zhu et al. 1995
).
Changes in endplate potential were reported in mice heterozygous for a
neuregulin-1 mutation (NRGIG allele), indicating a
rate-limiting function of the factor in maintaining high AChR
concentrations at the endplate (Sandrock et al. 1997
). We analyzed
synapse formation in rescued erbB2 and in erbB3
mutant embryos. Despite a general disorganization of phrenic and
intercostal nerves, AChR clustering and postsynaptic expression of
-AChR, RI-PKA, AChE, and
-AChR can occur. Moreover, ultrastructural specialization
such as synaptic vesicle accumulations, active zones, and postsynaptic
densities were observed. Thus, synaptogenesis is initiated, and the
first steps of synaptic maturation occur. Synapses that formed in the
rescued erbB2 and in erbB3 mutants appear at least
partially functional, because mutant embryos move at E16.5, albeit less
than control animals. At birth, spontaneous motion is not observed,
although prolonged tactile stimulation can occasionally result in
trunk, but not in limb movement. Skeletal muscle expresses
erbB2, erbB3, and erbB4, but only one of
these receptors is lacking in our mutants; the remaining receptors
might thus function in a redundant manner in the control of
postsynaptic gene expression. We did, however, detect ectopic AChR
clusters and nerve sprouting in the mutant mice and broadening of bands of nuclei that express these genes. This may reflect a failure of
effective synapse maturation due to impaired neuregulin signaling at
the synapse. However, the absence of terminal Schwann cells might also
contribute to these changes. Quantitative changes in postsynaptic gene
expression are pronounced in the diaphragm but not in intercostal
muscle, which appears to reflect the early withdrawal of the phrenic
nerve rather than a genuine difference in the control of postsynaptic
gene expression.
Terminal Schwann cells cap the neuromuscular junction and modulate
synaptic transmission, affect regeneration of synapses in paralyzed or
partially denervated muscle, and have been implicated in the
maintenance of the neuromuscular synapse (Balice 1996
; Son et al. 1996
;
Ullian and Barres 1998
). Here, we demonstrate that synapses are formed
and are stable over several days during intrauterine development in the
absence of terminal Schwann cells. However, their absence may
contribute to alterations in morphology of synapses, nerves, and nerve
sprouting that are observed in rescued erbB2 and in
erbB3 mutants.
| |
Materials and methods |
|---|
|
|
|---|
Construction and expression of the Nkx2.5erbB2 allele
The structure of the Nkx2.5 gene has been described (Lyons
et al. 1995
). To generate the Nkx2.5erbB2 allele, a
targeting vector was constructed that fuses rat erbB2 cDNA (Bargmann et
al. 1986
) to the start codon of Nkx2.5 in exon 1. The inserted
fragment contains, in addition, SV40 splice donor and acceptor sites,
as well as a poly(A) addition sequence that derives from the pSV2neo
plasmid (Bargmann et al. 1986
). For selection of ES cells, the
targeting vector also contained neomycin resistance cassette
(neo) and the thymidine kinase (tk) gene. Gene
targeting in ES cells and the generation of mice that carry the
Nkx2.5erbB2 allele was performed as described (Meyer
and Birchmeier 1995
). Routine genotyping was performed by PCR. Rat
erbB2 transcripts that derive from the Nkx2.5erbB2
allele were identified by RT-PCR. RNA from different tissues was
isolated by the use of TRIzol and a RT-PCR kit (GIBCO-BRL). Primers
used for the amplification hybridize to the 3'-nontranslated sequence and are located upstream and downstream of the SV40 splice site present in the transcript (Bargmann et al. 1986
).
In situ hybridization, histology, immunohistochemistry, and microscopy
Whole-mount in situ hybridization was performed as described
(Britsch et al. 1998
). To allow better access of hybridization solutions, mouse embryos at E12.5 were cut into halves and, from E15.5
and E18.5 embryos, rib cages and attached muscles of the thorax
(intercostal, diaphragm muscles, and some associated muscles of the
abdominal wall) were dissected prior to hybridization.
For histological analysis, mouse embryos or tissues were fixed in 4% PFA for several days at 4°C, dehydrated, and embedded in Technovit 7100 (Kulzer); 4- to 6-µm sections were stained with hematoxylin/eosin or with toluidine blue. For electron microscopy, embryos were fixed in glutaraldehyde and embedded in Durcupan. Ultrathin sections were then cut, contrasted with lead citrate, and viewed on a Zeiss EM910 electron microscope.
For immunohistological analysis, the embryos were prefixed, the
diaphragms or thoracic walls were dissected, postfixed in 4% PFA,
blocked with 20% goat serum (GS) in PBT (PBS/0.1%
Tween-20), and incubated with anti-GAP43, anti-L1, anti-S100 polyclonal
(Daco) antibodies, or rhodamine-labeled
-bungarotoxin in PBT
containing 5% goat serum at 4°C overnight. Cy2-conjugated
anti-rabbit IgG (1:300; Dianova) was used as secondary antibody.
The samples were examined with a Leica confocal microscope. Whole-mount
immunhistochemistry on E12.5 embryos was performed on embryos that were
cut into halves with polyclonal rabbit anti-L1 antibodies and
peroxidase-coupled goat anti-rabbit antibodies. Embryos were cleared in
benzyl alcohol/benzyl benzoate (1:2).
Motoneuron and sensory neuron counts
Embryos were prefixed in PFA, and appropriate segments of the spinal cord were dissected, with the attached dorsal root ganglia as reference points to determine the axial level. After postfixation, dorsal root ganglia were removed to improve access of the hybridization solutions, and whole-mount in situ hybridization with a VAChT-specific probe was performed. The stained tissue was embedded in plastic and cut into 6-µm sections. Every third section was examined, the numbers of nuclei located in the ventral horn that were surrounded by blue-stained cytoplasm were counted, and the averages of nuclei per section were determined. For each animal, the average numbers of motoneurons were determined on different axial levels. The data displayed are mean numbers of the averages of several animals.
Embryos or segments containing L4 and L5 dorsal root ganglia were embedded in Technovit 7100 (Kulzer). Serial sections (6 µm) through L4 and L5 dorsal ganglia were stained with toluidine blue and every third section was counted. In ganglia of E14.5, E16.5, and E18.5 embryos, cells with a clear nucleus and nucleoli were counted; in ganglia from E12.5 embryos, total cell numbers were determined. Counts were not corrected for double or split nucleoli.
| |
Acknowledgments |
|---|
We thank D. Wolpwitz (New York) for advice on counting of
motoneurons, K. Jessen (London) for information on unpublished data and
for pointing out patched as a marker for the perineurium, S. Burden
(New York) and H.-R. Brenner (Basel) for helpful discussions, Y. Yamaai
for help with the anatomical analysis of the mutants, and F. Rathjen
(Berlin) for a gift of anti-L1 antibodies. We also thank the following
scientists who have provided plasmids used in this study: Sox10, M. Wegner (Hamburg); RI subunit of PKA, M. Weiss (Paris) and S. McKnight
(Seattle); AChE, C. Legay (Paris); patched, M. Scott (Stanford); VAChT,
J. Dedman (Cincinnati) and D. Wolpowitz (New York);
-AChR and
-AChR, V. Witzemann (Heidelberg). We are grateful to A. Rehaus, K. Gottschling, and S. Buchert for expert technical assistance, M. Strehle
for help with preparation of Figure 1, as well as W. Birchmeier, A. Garratt, G. Mashour, and F. Rathjen for critical reading of the
manuscript. This work was supported by grants from GIF, DFG, and BMBF
to C.B.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked `advertisement' in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Footnotes |
|---|
Received May 17, 1999; revised version accepted August 18, 1999.
4 Present address: Zentrum für Molekulare Neurobiologie, 20251 Hamburg, Germany.
5 Corresponding author.
E-MAIL cbirch{at}mdc-berlin.de; FAX +49-30-9406 3765.
| |
References |
|---|
|
|
|---|
/GABP
.
Genes & Dev.
12:
3074-3083This article has been cited by other articles:
![]() |
Z. FENG and C.-P. KO The Role of Glial Cells in the Formation and Maintenance of the Neuromuscular Junction Ann. N.Y. Acad. Sci., June 1, 2008; 1132(1): 19 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. |